ESM1 Antikörper

Produktnummer ABIN1589869

Produktdetails anti-ESM1 Antikörper

Target: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ESM1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: Endocan/ESM-1 antibody

Spezifität: Recombinant mouse ESM-1

Produktmerkmale: Chromosomal location: 13 D2.2, 13

Aufreinigung: Protein A purified

Immunogen: Recombinant mouse ESM-1 (ABIN1589771)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western Blot: use at 1-5 μg/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: PBS

Handhabung: Centrifuge vial prior to opening.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

Haltbarkeit: 24 months

Details zu ESM1

Target: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Andere Bezeichnung: Endocan/ESM-1 (ESM1 Produkte)

Synonyme: ESM1 antikoerper, zgc:153027 antikoerper, 0610042H23Rik antikoerper, AV004503 antikoerper, ESM-1 antikoerper, Pg25 antikoerper, endocan antikoerper, endothelial cell specific molecule 1 antikoerper, endothelial cell-specific molecule 1 antikoerper, ESM1 antikoerper, esm1 antikoerper, Esm1 antikoerper

Hintergrund: Esm1, ESM-1, AV004503, 0610042H23Rik,Endocan (endothelial cell proteoglycan), also known as endothelialcell specific molecule1 (ESM-1), is a 50 kDa monomeric, secreted, cysteinerich proteoglycan identified initially in endothelial cells of the kidney and lung. Mouse Endocan is synthesized as a 184 amino acid (aa) precursor that contains a 21 aa signal sequence and a 20 kDa, 163 aa mature region. The N-terminal 2/3 of the molecule contains 18 cysteine residues and there are no potential N-linked glycosylation sites. Based on human Endocan, there are at least two potential O-linked glycosylation sites, one of which will likely be utilized on Ser at position # 136 of the mature molecule. The posttranslational modification is approximately 30 kDa in size. It consists of a single dermatan sulfate chain that contains 4O sulfated N-acetyl galactosamine with αiduronate. This chain is suggested to bind HGF and contribute to HGF mitogenic activity. Mature mouse Endocan shares 96 % and 74 % aa identity with rat and human Endocan, respectively. In human, there is a potential for an alternate splice variant. It shows a deletion of aa 82-131, a range which would not remove the dermatan sulfate attachment site. It is not known if such a splice form exists in mouse. Endocan is expressed by endothelial cells, adipocytes, bronchial epithelium and distal renal tubular epithelium. It is upregulated by TNFα and VEGF, and is known to bind to LFA1 (integrin αLβ2) on the surface of PBMCs, blocking LFA1 interaction with ICAM1. Normal circulating levels of Endocan are approximately 1 ng/mL.

Gen-ID: 71690

NCBI Accession: NM_023612, NP_076101

UniProt: Q9QYY7

Pathways: Growth Factor Binding